Lahey Hospital & Medical Center’s Cardiovascular Medicine Department has embraced using interventional cardiology to treat ...
Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the NEXUS (R) ...
Endospan, an Israel-based developer of solutions for the endovascular repair of aortic arch disease, announced that the FDA ...
Endospan, a privately-held company pioneering solutions for the endovascular repair of aortic arch disease, today announced ...
Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissectionsATLANTA, ...
Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissections ATLANTA, April 7, 2026 ...
The global Endovascular Aneurysm Repair (EVAR) Market is on a strong growth trajectory, estimated at USD 3.3 billion in 2025 and projected to reach USD 5.3 billion by 2035, reflecting a compound ...
FDA has approved new labeling for Medtronic’s Endurant stent graft system. The Dublin-based company said the labeling approval adds ruptured abdominal aortic aneurysm (rAAA) clinical evidence and ...
Over the past decades, great progress has been made in the treatment modalities for aortic arch diseases. Open surgical repair is considered the gold standard for patients suitable for surgery, but is ...
A 70-year-old man at Kauvery Hospital, Tirunelveli, underwent a successful Endovascular Aneurysm Repair (EVAR) for an abdominal aortic aneurysm, after a sudden size increase threatened a rupture. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results